Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications in Oncology
P1.01-06 Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy -Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.12-12 a Systematic Review and Meta-Analysis of Early and Late Survival Following Anti-Cancer Therapies for Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.13-01 Brigatinib Use in England – Where Next?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.14-21 Circulating Biomarkers in Thymic Epithelial Tumors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P115 Clinical Outcome of Crizotinib in Diverse ALK Fusion Partners and Different Detection Methods Treatment Naïve Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA01.02 the Estimate of Shrinking Field and SIB Radiotherapy Guided by 18f-FDG PET/CT in Locally Advanced NSCLC Patients: A Phase 2 Randomized Clinical
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.09-03 Alteration of Gut Microbiome in Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA10.07 Resistance Mechanisms of Osimertinib in Chinese Non-Small Cell Lung Cancer Patients: Analysis From AURA17 Trial
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-75 Utility of cfDNA Testing for Acquired Resistance: The Memorial Sloan Kettering Experience With Plasma EGFR T790M Clinical Testing
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.04-28 Can Ipilimumab Restore Immune Response in Advanced NSCLC After Progression on Anti PD1/PDL1 Agents?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
‹
505
506
507
508
509
510
511
›